Literature DB >> 3359831

Posterior mediastinal mass with intraspinous extension.

S G Joseph1, C J Tellis.   

Abstract

The differential diagnosis of masses in the posterior mediastinum includes neurogenic neoplasms, cysts, esophageal tumors, infectious processes including abscesses, and disorders of the thoracic spine. Nonoperative procedures, including transcutaneous and transbronchial biopsies and thoracoscopy, may not lead to a definitive diagnosis. We present two cases in which a neurogenic tumor, with and without significant spinal canal involvement, was diagnosed at thoracotomy after several nondiagnostic procedures. The appearance of the mass on chest roentgenogram can be used to narrow the preoperative differential diagnosis between ganglion-series and nerve-sheath tumors. The utility of computerized tomography of the chest, in addition to the chest roentgenogram, in assessing the bony involvement of the thoracic tumor is illustrated. The role of magnetic resonance imaging is yet to be fully defined in this entity. These lesions may be approached by separate thoracic and neurosurgical approaches, or by a combined, single-staged procedure. These cases and a review of the literature support the use of the single-staged approach.

Entities:  

Mesh:

Year:  1988        PMID: 3359831     DOI: 10.1378/chest.93.5.1101

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  Surgically treated dumbbell schwannoma arising in the brachial plexus with intrathoracic extension.

Authors:  Masato Kanzaki; Tokuro Ohtsuka; Tetsuya Obara; Hiroshi Yamamoto; Takamasa Onuki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-02

2.  Single-stage removal of thoracic dumbbell tumors from a posterior approach only with costotransversectomy.

Authors:  Kei Ando; Shiro Imagama; Norimitsux Wakao; Kenichi Hirano; Ryoji Tauchi; Akio Muramoto; Hiroki Matsui; Tomohiro Matsumoto; Yukihiro Matsuyama; Naoki Ishiguro
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.